Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Hypertension meds recalled due to cancer risk | Office-based cardiac CT | A new imaging technique for blood vessels
Thursday, March 24, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

FDA announces recall of hypertension medications due to potential cancer risk

The voluntary recall includes quinapril HCl/hydrochlorothiazide tablets sold by Pfizer and authorized generics of that same medication. 

READ MORE >
These quinapril HCl/hydrochlorothiazide tablets, which Pfizer sells under the name Accuretic, are included in the voluntary FDA recall.
Share on Twitter Share on Facebook Share on Linkedin

FDA announces recall of hypertension medications due to potential cancer risk

Share on Twitter Share on Facebook Share on Linkedin
These quinapril HCl/hydrochlorothiazide tablets, which Pfizer sells under the name Accuretic, are included in the voluntary FDA recall.
The voluntary recall includes quinapril HCl/hydrochlorothiazide tablets sold by Pfizer and authorized generics of that same medication. 
READ MORE >

VIDEO: Office-based cardiac CT and FFR-CT offer a new business model

In a new video, Evans Pap­pas, MD, and Sujith Kalathiveetil, MD, both of Duly Health and Care in suburban Chicago, explain the shift toward office-based cardiac CT evaluations and the role of FFR-CT. 

READ MORE >
A cardiac CT scan being performed on a Cardiograph dedicated cardiac CT scanner at a Duly Health and Care outpatient clinic. Photo by Dave Fornell
Share on Twitter Share on Facebook Share on Linkedin

VIDEO: Office-based cardiac CT and FFR-CT offer a new business model

Share on Twitter Share on Facebook Share on Linkedin
A cardiac CT scan being performed on a Cardiograph dedicated cardiac CT scanner at a Duly Health and Care outpatient clinic. Photo by Dave Fornell
In a new video, Evans Pap­pas, MD, and Sujith Kalathiveetil, MD, both of Duly Health and Care in suburban Chicago, explain the shift toward office-based cardiac CT evaluations and the role of FFR-CT. 
READ MORE >

New-look imaging technique could change the way we see blood vessels

The new method, still being tested with mouse models, could help clinicians see blood vessels with improved clarity. 

READ MORE >
The new imaging method VascuViz includes a quick-setting polymer mixture to fill blood vessels and make them visible in multiple imaging techniques. It enables visualization of the structure of a tissue’s vasculature, which in conjunction with detailed mathematical models or complementary images of other tissue elements can clarify the complex role of blood flow in health and disease. Watch a video example of this technology
Share on Twitter Share on Facebook Share on Linkedin

New-look imaging technique could change the way we see blood vessels

Share on Twitter Share on Facebook Share on Linkedin
The new imaging method VascuViz includes a quick-setting polymer mixture to fill blood vessels and make them visible in multiple imaging techniques. It enables visualization of the structure of a tissue’s vasculature, which in conjunction with detailed mathematical models or complementary images of other tissue elements can clarify the complex role of blood flow in health and disease. Watch a video example of this technology
The new method, still being tested with mouse models, could help clinicians see blood vessels with improved clarity. 
READ MORE >

Thrombolysis vs. surgery for prosthetic valve thrombosis

The three-month mortality rate was 2.4% after thrombolysis and 18.7% after surgery.

READ MORE >
Examples of prosthetic heart valve thrombus formation on the valve leaflets. A new study shows better outcomes using tPA vs. surgery to remove the clots. Valve thrombosis. Images from Mayo Clinic
Share on Twitter Share on Facebook Share on Linkedin

Thrombolysis vs. surgery for prosthetic valve thrombosis

Share on Twitter Share on Facebook Share on Linkedin
Examples of prosthetic heart valve thrombus formation on the valve leaflets. A new study shows better outcomes using tPA vs. surgery to remove the clots. Valve thrombosis. Images from Mayo Clinic
The three-month mortality rate was 2.4% after thrombolysis and 18.7% after surgery.
READ MORE >

Featured Articles

Older LAAO patients, especially women, face a higher risk of complications

Researchers explored data from the National Inpatient Sample, sharing their findings in the American Journal of Cardiology.

READ MORE >
Illustration of a left atrial appendage occlusion (LAAO) procedure using a Watchman device. Image courtesy of Johns Hopkins Medicine. #LAA #LAAO
Share on Twitter Share on Facebook Share on Linkedin

Older LAAO patients, especially women, face a higher risk of complications

Share on Twitter Share on Facebook Share on Linkedin
Illustration of a left atrial appendage occlusion (LAAO) procedure using a Watchman device. Image courtesy of Johns Hopkins Medicine. #LAA #LAAO
Researchers explored data from the National Inpatient Sample, sharing their findings in the American Journal of Cardiology.
READ MORE >

DOACs may reduce the risk of dementia among AFib patients by 50%

Nearly 19,000 patients with newly diagnosed atrial fibrillation were included in the team's analysis. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

DOACs may reduce the risk of dementia among AFib patients by 50%

Share on Twitter Share on Facebook Share on Linkedin
Nearly 19,000 patients with newly diagnosed atrial fibrillation were included in the team's analysis. 
READ MORE >

Risk of vaccine-related heart damage after booster shot lower than it was after first 2 doses

The new analysis included data from more than 126,000 vaccinations. 

READ MORE >
Vaccination
Share on Twitter Share on Facebook Share on Linkedin

Risk of vaccine-related heart damage after booster shot lower than it was after first 2 doses

Share on Twitter Share on Facebook Share on Linkedin
Vaccination
The new analysis included data from more than 126,000 vaccinations. 
READ MORE >

In Other News

Change Healthcare reportedly seeking ‘sizable’ breakup fee if UnitedHealth deal falls through

Members of the Nashville, Tennessee, imaging vendor’s board have recently discussed such a “reverse fee,” which was not part of its original agreement with UHG. 

READ MORE >
Healthcare M&A, mergers and acquisitions business deal.
Share on Twitter Share on Facebook Share on Linkedin

Change Healthcare reportedly seeking ‘sizable’ breakup fee if UnitedHealth deal falls through

Share on Twitter Share on Facebook Share on Linkedin
Healthcare M&A, mergers and acquisitions business deal.
Members of the Nashville, Tennessee, imaging vendor’s board have recently discussed such a “reverse fee,” which was not part of its original agreement with UHG. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme